Interstitial pneumonia from mitomycin

E. S. Orwoll, P. J. Kiessling, J. R. Patterson

Research output: Contribution to journalArticlepeer-review

80 Scopus citations


Pulmonary disease has been associated with several chemotherapeutic agents but has not been reported in patients receiving the alkylating agent mitomycin (Mutamycin). We describe here the cases of three patients who developed interstitial pneumonia while receiving mitomycin therapy. Their clinical features included dyspnea, cough, and occasionally fever; reticular infiltrates were seen on chest roentgenogram. Histologically, diffuse alveolar septal edema, mononuclear-cell interstitial infiltrates, hypertrophy of alveolar lining cells, and alveolar septal collagen deposition were characteristic. Treatment with corticosteroids was associated with a rapid therapeutic response in all three patients.

Original languageEnglish (US)
Pages (from-to)352-355
Number of pages4
JournalAnnals of internal medicine
Issue number3
StatePublished - 1978
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Interstitial pneumonia from mitomycin'. Together they form a unique fingerprint.

Cite this